These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 22001382)
1. What tubulin drugs tell us about microtubule structure and dynamics. Amos LA Semin Cell Dev Biol; 2011 Dec; 22(9):916-26. PubMed ID: 22001382 [TBL] [Abstract][Full Text] [Related]
2. Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamics. Stec-Martyna E; Ponassi M; Miele M; Parodi S; Felli L; Rosano C Curr Cancer Drug Targets; 2012 Jul; 12(6):658-66. PubMed ID: 22385515 [TBL] [Abstract][Full Text] [Related]
3. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization. Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796 [TBL] [Abstract][Full Text] [Related]
4. The Unique Binding Mode of Laulimalide to Two Tubulin Protofilaments. Churchill CD; Klobukowski M; Tuszynski JA Chem Biol Drug Des; 2015 Aug; 86(2):190-9. PubMed ID: 25376845 [TBL] [Abstract][Full Text] [Related]
5. Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability. Smith JA; Wilson L; Azarenko O; Zhu X; Lewis BM; Littlefield BA; Jordan MA Biochemistry; 2010 Feb; 49(6):1331-7. PubMed ID: 20030375 [TBL] [Abstract][Full Text] [Related]
6. Disruption of tubulin polymerization and cell proliferation by 1-naphthylarsonic acid. Mahinpour R; Riazi G; Shokrgozar MA; Sarbolouki MN; Ahmadian S; Douraghi M; Hadi Alijanvand H; Azadmanesh K; Heidari M; Naghdi Gheshlaghi Z; Moosavi-Movahedi AA Cell Biol Int; 2012 Apr; 36(4):403-8. PubMed ID: 22214203 [TBL] [Abstract][Full Text] [Related]
7. The Mechanism of the Interactions of Pironetin Analog/Combretastatin A-4 Hybrids with Tubulin. Torijano-Gutiérrez S; Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA Arch Pharm (Weinheim); 2015 Aug; 348(8):541-7. PubMed ID: 26085125 [TBL] [Abstract][Full Text] [Related]
10. The binding sites of microtubule-stabilizing agents. Field JJ; Díaz JF; Miller JH Chem Biol; 2013 Mar; 20(3):301-15. PubMed ID: 23521789 [TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of action of microtubule-stabilizing anticancer agents. Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720 [TBL] [Abstract][Full Text] [Related]
12. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization. Khrapunovich-Baine M; Menon V; Verdier-Pinard P; Smith AB; Angeletti RH; Fiser A; Horwitz SB; Xiao H Biochemistry; 2009 Dec; 48(49):11664-77. PubMed ID: 19863156 [TBL] [Abstract][Full Text] [Related]
13. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization. Coluccia A; Sabbadin D; Brancale A Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885 [TBL] [Abstract][Full Text] [Related]
14. NMK-TD-100, a novel microtubule modulating agent, blocks mitosis and induces apoptosis in HeLa cells by binding to tubulin. Bhattacharya S; Kumar NM; Ganguli A; Tantak MP; Kumar D; Chakrabarti G PLoS One; 2013; 8(10):e76286. PubMed ID: 24116100 [TBL] [Abstract][Full Text] [Related]
15. Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin. Tyagi C; Gupta A; Goyal S; Dhanjal J; Grover A BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S3. PubMed ID: 25521775 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of microtubule dynamics and force generation examined with computational modeling and electron cryotomography. Gudimchuk NB; Ulyanov EV; O'Toole E; Page CL; Vinogradov DS; Morgan G; Li G; Moore JK; Szczesna E; Roll-Mecak A; Ataullakhanov FI; Richard McIntosh J Nat Commun; 2020 Jul; 11(1):3765. PubMed ID: 32724196 [TBL] [Abstract][Full Text] [Related]
17. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents. Tangutur AD; Kumar D; Krishna KV; Kantevari S Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738 [TBL] [Abstract][Full Text] [Related]
18. Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells. Mukhtar E; Adhami VM; Sechi M; Mukhtar H Cancer Lett; 2015 Oct; 367(2):173-83. PubMed ID: 26235140 [TBL] [Abstract][Full Text] [Related]
19. Binding of dihydroxynaphthyl aryl ketones to tubulin colchicine site inhibits microtubule assembly. Gutierrez E; Benites J; Valderrama JA; Calderon PB; Verrax J; Nova E; Villanelo F; Maturana D; Escobar C; Lagos R; Monasterio O Biochem Biophys Res Commun; 2015 Oct; 466(3):418-25. PubMed ID: 26365353 [TBL] [Abstract][Full Text] [Related]
20. Sequestration of free tubulin molecules by the viral protein NSP2 induces microtubule depolymerization during rotavirus infection. Martin D; Duarte M; Lepault J; Poncet D J Virol; 2010 Mar; 84(5):2522-32. PubMed ID: 20032187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]